Last update 20 Mar 2025

Arlocabtagene autoleucel

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
GPRC5D-directed CAR-T Cell(Juno Therapeutics)
Target
Action
inhibitors
Mechanism
GPRC5D inhibitors(G-protein coupled receptor family C group 5member D inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 3
United States
-
Refractory Multiple MyelomaPhase 2
Australia
21 Mar 2024
Refractory Multiple MyelomaPhase 2
United States
21 Mar 2024
Refractory Multiple MyelomaPhase 2
Canada
21 Mar 2024
Refractory Multiple MyelomaPhase 2
Japan
21 Mar 2024
Relapse multiple myelomaPhase 2
United States
21 Mar 2024
Relapse multiple myelomaPhase 2
Canada
21 Mar 2024
Relapse multiple myelomaPhase 2
Japan
21 Mar 2024
Relapse multiple myelomaPhase 2
Australia
21 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
30
(qjnblwglks) = fnzhxiamjw fwqfemgapk (bujwqwvwry )
Positive
14 May 2024
Phase 1
21
overall
(vqgqobdysn) = buyfgfrwri zxqrljukfu (rqzgkxyoud )
Positive
15 Nov 2022
(kkczbuykxj) = chlasduxbk qlohgnkrqd (qaqgaekwvb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free